Related Experiment Video
Updated: May 17, 2026
16:59
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Published on: October 10, 2012
Insulin gene therapy from design to beta cell generation
Ahter D Sanlioglu1, Hasan Ali Altunbas, Mustafa Kemal Balci
1Human Gene and Cell Therapy Center, Antalya, Turkey.
Expert Reviews in Molecular Medicine
|October 16, 2012
Summary
Insulin gene therapy offers potential for type-1 diabetes (T1D) treatment by providing insulin and C-peptide. Current challenges include controlling insulin secretion and targeting specific cells for sustained therapeutic effects.
Area of Science:
- Biomedical research
- Endocrinology
- Gene therapy
Background:
- Conventional insulin therapy and analogues offer limited glycemic control benefits for type-1 diabetes (T1D).
- Insulin deficiency is a primary consequence of T1D, making insulin gene therapy an attractive alternative.
- Existing gene therapy approaches face challenges with delayed or transient gene expression.
Purpose of the Study:
- To review the current status and challenges of insulin gene therapy for type-1 diabetes.
- To explore novel strategies for achieving sustained and controlled insulin gene expression.
- To highlight advancements in generating functional beta cells via transdifferentiation for diabetes treatment.
Main Methods:
- Review of existing literature on insulin gene therapy, gene transfer vectors, and cell-targeting strategies.
- Analysis of challenges related to achieving sustained insulin expression and regulated secretion.
- Examination of recent advancements in beta cell generation through cell transdifferentiation.
Main Results:
- Sustained insulin gene expression is achievable with current vectors, providing basal insulin coverage.
- Controlling postprandial hyperglycemia remains a significant challenge due to difficulties in regulating insulin secretion.
- Targeting enteroendocrine cells presents potential but faces practical implementation hurdles.
Conclusions:
- Insulin gene therapy holds promise for T1D but requires overcoming limitations in gene expression control and cell targeting.
- Transdifferentiation technologies offer a promising avenue for generating authentic beta cells.
- Further research is needed to optimize insulin gene therapy for effective diabetes management.
Related Concept Videos
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...